Integrated Quantitative Investments Portfolio holdings
Top Buys
| 1 |
ING
ING
|
+$7.49M |
| 2 |
Lloyds Banking Group
LYG
|
+$4.96M |
| 3 |
Banco Santander
SAN
|
+$4.71M |
| 4 |
Nomura Holdings
NMR
|
+$4.27M |
| 5 |
Banco Bilbao Vizcaya Argentaria
BBVA
|
+$3.93M |
Top Sells
| 1 |
Jackson Financial
JXN
|
+$2.57M |
| 2 |
Microsoft
MSFT
|
+$2.49M |
| 3 |
THR
Thermon Group Holdings
THR
|
+$2.08M |
| 4 |
Mastercard
MA
|
+$2.02M |
| 5 |
HealthEquity
HQY
|
+$2M |
Sector Composition
| 1 | Financials | 27.89% |
| 2 | Technology | 26.14% |
| 3 | Industrials | 13.01% |
| 4 | Healthcare | 9.62% |
| 5 | Consumer Discretionary | 7.65% |
Similar funds
Integrated Quantitative Investments's Q1 2026 Portfolio in Review
As of Q1 2026, Integrated Quantitative Investments held 552 positions worth $551M, up 18% from $466M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Integrated Quantitative Investments deployed $92.7M of net new capital in Q1 2026, opening 164 new positions and adding to 130 existing holdings. Its largest new stake was Lloyds Banking Group: 904,608 shares worth $4.55M.
By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 22% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Microsoft, an estimated $2.49M trimmed.
- Integrated Quantitative Investments's largest Q1 2026 buy was Lloyds Banking Group: 904,608 shares worth $4.55M.
- Integrated Quantitative Investments added most to ING in Q1 2026, an estimated $7.49M increase.
- Integrated Quantitative Investments's biggest Q1 2026 reduction was Microsoft, cutting an estimated $2.49M.
- Integrated Quantitative Investments fully exited Jackson Financial in Q1 2026, selling an estimated $2.57M.
- Integrated Quantitative Investments's ten largest holdings make up 19% of its $551M portfolio in Q1 2026.
- Integrated Quantitative Investments opened 164 new positions and closed 167 in Q1 2026.
- Integrated Quantitative Investments's portfolio value rose 18% quarter-over-quarter to $551M.
Based on Integrated Quantitative Investments's 13F filing for Q1 2026, filed 13 May 2026.